Except for yesterday and last Monday OPTR has had really low volume since 10/5. IMO the big boys already had the news -- it was a reiteration. Still, decent volume today, following yesterday's blast.
Earnings due 11/4 -- two weeks away. I think CBST CC has alerted the masses to the value of OPTR's launch. If CBST is moving its CDAD drug into phase 3, it will be some time -- 2+ years? -- before that phase is completed. Even then, will they have any better results?